Table 1.
Cardiac Biomarker |
Sensor Specification | Method | Sensing Strategy | Sample Matrices | Detection Rang | Limit of Detection (LOD) | Ref. |
---|---|---|---|---|---|---|---|
Mb | polystyrene microplate | personal glucose meter (PGM) readout | antibody–Mb–aptamer sandwich | serum samples | 50 pM–200 nM | 50 pM | [71] |
cTnI | Au electrode/thiolated apt. | SWV, Fc-SiNPs | label-free | buffer | 1−10,000 pM | 1.0 pM | [75] |
cTnI | AuNPs, Ti Foil/HS-apt. | DPV, [Fe(CN)6]3−/4− | Label-free | human serum samples | 1–1100 pM | 0.18 pM | [76] |
cTnI | Au electrode/macroporous Au nanostructure/Apt. | DPV, [Fe(CN)6]3−/4− | label-free | spiked human serum samples | 0.05–5.0 ng mL−1 | 23 pg mL−1 | [77] |
TnI | array of Au nanodumbbells/76-mer TnI aptamer | DPV [Fe(CN)6]3−/4− |
label-free | blood serum samples | 0.05–500 ng mL−1 | 8.0 pg mL−1 | [78] |
cTnI | SPCE/AuNPs/electropolymerized conductive polymer/Apt. | amperometry, hydrazine, H2O2 | apt. pair-based sandwich type | serum | 1–100 pM (0.024–2.4 ng/mL) |
1.0 pM (24 pg/mL) |
[79] |
cTnI | GC/N-prGO/COOH/PEG-apt. | DPV | Label-free | serum, saliva | 0.001–100 ng mL−1 | 0.88 pg mL−1 | [80] |
cTnI | Apt.–MoS2 nanosheets | EIS, [Fe(CN)6]3−/4− |
label-free | human blood samples | 10 pM to 1.0 μM | 0.95 pM | [81] |
Au@SiO2@Au/aptamer- | 10 pM–10.0 μM | 1.23 pM | |||||
cTnI | DNA nanotetrahedron (NTH)/dual-apt. (dAPT), magnetic metal organic frameworks (mMOFs), Fe3O4@UiO-66, Au@Pt NPs | DPV hydroquinone, H2O2 | sandwich-structure | human serum | 0.01–100 ng·mL−1 | 5.7 pg mL−1 | [82] |
cTnI | Au electrode/apt. probe 2 (P2) | SWV MB |
sandwich-structure | human serum, urine saliva | 0.5–100 ngmL−1 | 0.04 ngmL−1 | [83] |
Mb | apt./rGO/CNT nanohybrid electrodes | CV direct electron transfer Mb |
label-free | buffer | 1 ng/mL–4 µg/mL | ~0.34 ng/mL | [84] |
Mb | Y-shape structure of dual-aptamer (DApt)- | DPV [Fe(CN)6]3−/4− |
label-free | human blood serum | 100 pM–40 nM | 27 pM | [85] |
Mb | apt.–black phosphorus nanostructured electrode | CV | direct electron transfer Mb | serum samples | 1 pg mL−1–16 µg mL−1 | 0.524 pg mL−1 | [86] |
Mb | meso-tetra (4-carboxyphenyl) porphyrin-AuNPs(TCPP–Gr/AuNPs)/apt. Mb | DPV | electron transfer by Mb | human serum samples | 2.0 × 10−11–7.7 × 10−7 M | 6.7 × 10−12 M | [87] |
Lys | Au electrode/Lys apt. | SWV Fc, [Ru(NH3)6]3+ |
signal on/off, label-free | human serum | 1.0 × 10−11–1.0 × 10−7 M | 0.8 pM | [88] |
Mb | GCE, PtSnNP CNTs/Mb-apt. | Amperometry, [Fe(CN)6]3−/4- | conformational change | Spiked human serum samples | 0.01–1 and 10 nM–200 nM | 2.2 ± 0.1 pM | [89] |
Mb | Apt/AuNPs/BNNSs/FTO | DPV [Fe(CN)6]3−/4− |
label free | human serum Hb, GOx, Ins., SOx |
0.1–100 µg/mL | 34.6 ng/mL | [90] |
cTnI Mb |
HsGDY@NDs/apt.strand | EIS [Fe(CN)6]3−/4− |
label-free | human serum | cTnI 0.00001–100 ng mL−1 Mb 0.01–1000 pg mL−1 |
cTnI 9.04 fg mL−1 Mb 9.04 fg mL−1 |
[91] |